Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

The Role of Gut Microbiota in Intestinal Inflammation with Respect to Diet and Extrinsic Stressors Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

December 11, 2025

  • Autoimmune Diseases
    Autoimmune Diseases

    Autoimmune disease is when the immune system mistakenly attacks the body's tissues, often linked to imbalances in the microbiome, which can disrupt immune regulation and contribute to disease development.

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2025-12-11

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was studied?

The review focuses on how gut microbiota influences intestinal inflammation, particularly in the context of diet and extrinsic stressors. The paper explores the interaction between microbiota dysbiosis and intestinal diseases such as inflammatory bowel disease (IBD). The authors examine the role of diet, antibiotics, sleep disturbance, physical activity, and environmental stressors like heat, cold, and pollutants in altering the gut microbiome, which could contribute to intestinal inflammation. Specifically, they address the microbial shifts that occur with these stressors and their potential to either promote or prevent inflammation in the gut.

Who was studied?

The paper highlights studies conducted in both animal models and human populations, providing insights into how changes in the gut microbiome are linked to diseases such as IBD. The studies primarily explore changes in the microbiota composition in response to dietary habits, extrinsic environmental factors, and physical or psychological stress. These factors were observed to influence the abundance of certain bacterial families and genera, such as Lactobacillus, Bifidobacterium, and Faecalibacterium, all of which play crucial roles in maintaining intestinal health. The findings offer valuable insights for clinicians working with IBD patients or those affected by dysbiosis due to external factors.

Most important findings

One of the most critical findings is the relationship between gut microbiota alterations and intestinal inflammation. The review reports that environmental and dietary stressors like high-fat diets and environmental pollutants can significantly alter the gut microbiota, promoting the growth of pro-inflammatory bacteria such as Enterobacteriaceae. The paper highlights the reduction in beneficial microbes like Lactobacillus and Faecalibacterium, which are known to produce anti-inflammatory metabolites like short-chain fatty acids (SCFAs). Furthermore, psychological stress was shown to exacerbate inflammation by reducing the proportion of beneficial bacteria and increasing the abundance of harmful microbes, which are associated with intestinal barrier dysfunction.

The paper discusses the beneficial effects of certain diets, such as the Mediterranean diet, on the gut microbiota composition. High fiber and prebiotic-rich foods were found to support the growth of beneficial bacteria, enhancing gut health and reducing inflammation. Conversely, western-style diets, rich in fats and sugars, were linked to higher levels of inflammatory bacteria, contributing to conditions like IBD.

Key implications

The findings underline the importance of addressing diet and extrinsic stressors when managing patients with intestinal inflammation or IBD. Clinicians should consider dietary interventions, such as increasing fiber intake and incorporating probiotic-rich foods, to help modulate the gut microbiota in favor of reducing inflammation. The review also suggests that managing stress and reducing exposure to harmful environmental factors, such as pollutants, can play a role in improving gut health. Probiotic treatments might also be a promising strategy to restore gut balance and prevent the progression of IBD. Further studies are necessary to fully understand the direct mechanisms linking stress, diet, and microbiota alterations to inflammation, especially in clinical settings.

Short-chain Fatty Acids (SCFAs)

Short-chain fatty acids are microbially derived metabolites that regulate epithelial integrity, immune signaling, and microbial ecology. Their production patterns and mechanistic roles provide essential functional markers within microbiome signatures and support the interpretation of MBTIs, MMAs, and systems-level microbial shifts across clinical conditions.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.